Published on 14/07/2025 10:03 AM
Hind Zinc in focus: Silver hits record high, MCX Silver crosses ₹1.14 lk/kg
#StocksInFocus | IT Stocks: Selling continues, #HCL, #TechMah, #LTIM report results this week, #NiftyIT down 1% pic.twitter.com/fNrSWqM6Pz
— CNBC-TV18 (@CNBCTV18Live) July 14, 2025
VIP Industries: CNBC-TV18 Newsbreak confirmed the deal done at ₹388/sh, stock down nearly 3%
Its Economy: Ashish Gupta, CIO, Axis AMC
Divi’s Laboratories fell nearly 3% and remains under pressure after MSN Laboratories won a patent dispute related to the heart drug Entresto.
Anthem Biosciences IPO Opens Today, Company Speaks to CNBC-TV18
Ajay Bhardwaj, CMD & CEO of Anthem Biosciences
Company Is a Partner To Global Innovators, Helping Them Research & Discover New Drugs
Revenue Flow Comes From Molecules That Are Discovered & Commercialised
Get Paid For The Milestones Achieved & Work On A Fee-for-service Model
Gawir Baig, CFO, Anthem Biosciences
Grown at 24% CAGR & Have Maintained Approximately 35% Margin
Expect to Maintain EBITDA Margin at Approximately 35%
Expect approximately ₹`300 Cr Cash Generation Per Year & Plan To Use It for Developing The 4th Facility
Defence stocks are trading lower, with all major names falling over 2%. Garden Reach Shipbuilders saw the steepest decline, sliding nearly 5% in early trade.
Shares of NCC rose nearly 2% after the company secured a significant contract from the Mumbai Metropolitan Region Development Authority (MMRDA).
#Q1Results #Live Updates: HCLTech, Tata Technologies, Ola Electric Mobility among key earnings todayhttps://t.co/1OPwoYqOuf
— CNBC-TV18 (@CNBCTV18Live) July 14, 2025
Vetri Subramaniam, UTI AMC, On CNBC-TV18
Valuations Are In The Fair Value Zone For Benchmark Indices
Challenging Territory For Investors In Terms Of Starting Valuations
Market Back To Where It Closed A Year Ago, But Valuations Are Not Cheaper
RBI’s Thought Process on Risk Weights Has Changed Significantly
FMCG Stocks Have Not Done Much in Recent Years
Earnings Trendline for Financial Stocks Will Be Higher as the RBI Is Now Supportive of Growth
Have More Relative Comfort in the Indian Healthcare Sector
#CNBCTV18Market | Market opens lower, #Nifty below 25,100 pic.twitter.com/GnpJaJR1tA
— CNBC-TV18 (@CNBCTV18Live) July 14, 2025
Prakash Diwan, Market Expert, said the VIP Industries stock has had a very elongated anticipation built around it. I think the deal is pretty well priced. If the market gives you a negative reaction to it, it could be an opportunity for some nibbling to start. But the real change will happen once the private equity owners settle in, and the plans to professionalise the business completely get underway, and that’s exactly what’s required out here. So that could take a couple of quarters. But as soon as those things are much more visible, it becomes a stronger bet because consumption, particularly around travel, is something which all of us are very positive on.
The second-order impact is going to be that Safari Industries will probably be more positive after this, because it gives them time to restore market share and get into some of the segments, while VIP resets itself to this new reality. So, from that perspective, it could be a faster tactical play, but VIP will give you a far better, solid foundation over the next six months.
On Glenmark, Diwan said the stock has reacted very positively on July 11, but if you get a chance to get in, the deal is still on. The money that they’re going to make from this research initiative is very much there. This is an opportunity where people who have missed out on Glenmark’s brilliant run would probably do that. We spoke about this at ₹1,000 levels, so you can see how smoothly and gradually it’s made its way to the ₹2,000 mark. So my sense is, these are opportunities to latch on to good names.
AU Small Finance Bank shares are drawing attention on Monday, July 14, after Kotak Institutional Equities lowered its rating on the stock but raised its target price by about 8%.
Read Full Article
RBI Directs Inclusion of NSDL Payments Bank in Second Schedule of the RBI Act, 1934
Alert: Banks In the 2nd Schedule Of the RBI Act, 1934, Are Considered ‘Scheduled Banks’
Here are a couple of stock recommendations by Mitessh Thakkar, Technical Analyst
Sell Adani Enterprises with a stop loss of ₹2,592 and a target of ₹2,480
Sell Bharti Airtel with a stop loss of ₹1,942 and a target of ₹1,860
Buy Dabur with a stop loss of ₹525 and a target of ₹543
Buy REC with a stop loss of ₹401 and a target of ₹420
On Religare
This could be a trend that sees the stock head towards ₹290 as the minimum short-term target, but there is a good chance that it might retest levels of ₹310, which was done in December 2024.
#RupeeCheck| Rupee opens at 86/$ vs Friday’s close of 85.80/$ pic.twitter.com/cpkZg9jOy9
— CNBC-TV18 (@CNBCTV18Live) July 14, 2025
Here are a couple of stock recommendations by Sudarshan Sukhani of Technical Trends
Buy KPIT Tech with a stop loss of ₹1,240
Buy Prestige Estates with a stop loss of ₹1,660
Buy REC with a stop loss of ₹390
Sell Minda Corp with a stop loss of ₹1,088
Hetal Dalal, President and COO, IIAS
Zee Is Sitting On ₹2,410 Crore, Did Not Support Raising Another ₹2,200 Crore Through Warrants
Don’t Favourably Look At Warrants Issue To Promoters, Allows Them To Ride The Share Price
Board Has Protected Puneet Goenka, Allowing Him To Run Co As CEO, This Disregards Shareholders’ View
Board Has Lost Confidence Of Investors, It’s Time The Board Stepped Down
Zee Ent Needs To Appoint An Independent Board
Shareholders Can Ask For An EGM And Demand An Independent Board
Karan Taurani, EVP, Elara Capital
Negative Development For Zee In Terms Of Share Price Performance
Focus Now On Growth And Lowering Of Losses In Zee5
Had The Promoter Undertaken A Premium Valuation For Convertible Warrants, The Resolution May Have Been Passed
Zee Music Could Also Get Similar Valuations Like Saregama And Tips Music
Zee Ent Is A Value Stock To Buy, Need To Monitor Operational Performance And Execution
Sources say Jane Street has deposited ₹4,843.5 crore, as instructed by SEBI in its interim order dated July 3.
SEBI had earlier barred the firm from the market and ordered the deposit.
Multiple companies that announced their dividends, bonus issues, and stock splits earlier, will have their record dates taking place during the course of the week. They include names like Kotak Mahindra Bank, Samvardhana Motherson, Ashok Leyland, and a host of others.
Here is a look at those companies
Kolte-Patil Developers Q1 Update
Collections Up 21.8% QoQ & Up 10.1% YoY At ₹550 Cr
Sales Value Up 2.3% QoQ & Up 13.3% YoY At ₹616 Cr
Rahul Chadha, Shikhara Investment, On CNBC-TV18
Positive On Select Midcap Banks; Q1 May Be Slightly Soft For The Sector
Consumer Discretionary Can Be Bought On Pullbacks, Prefer Discretionary Over Staples
Positive On Hotels, Travel & Select Q-commerce Names From A Medium-term PerspectiveAs many as nine Pharma stocks, from Divi’s Laboratories to Sun Pharma, will be in focus on Monday, July 14, some due to their respective news flow, while the rest due to brokerage commentary.
Some of the stocks to watch are Avenue Supermarts Ltd, VIP Industries, Glenmark Pharma, Gland Pharma Ltd, NCC Ltd , Wockhardt Ltd, Castrol India, Ajmera Realty.
#VIPIndustries | CNBC-TV18 Newsbreak confirmed, #MultiplesConsortium to buy co
▶️#DilipPiramal & family in definitive agmt with Multiples Consortium
▶️Promoters to sell up to 32% stake for ₹1,763.3 cr
▶️Multiples equity announces open offer to acquire addl 26% stake at… https://t.co/hriKONFVDw pic.twitter.com/TZc0wA5fDq
— CNBC-TV18 (@CNBCTV18Live) July 14, 2025
Glenmark Pharmaceuticals Ltd. has received a warning letter from the US Food and Drug Administration (USFDA) for its facility in Indore, Madhya Pradesh, the company said in an exchange filing on Sunday, July 13.NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.